Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price was up 16% during mid-day trading on Wednesday . The stock traded as high as GBX 29 ($0.39) and last traded at GBX 29 ($0.39). Approximately 361,882 shares changed hands during mid-day trading, an increase of 349% from the average daily volume of 80,634 shares. The stock had previously closed at GBX 25 ($0.33).
Celadon Pharmaceuticals Price Performance
The company has a 50-day simple moving average of GBX 40.97 and a 200-day simple moving average of GBX 71.41. The stock has a market cap of £18.59 million, a PE ratio of -200.00 and a beta of -0.25. The company has a debt-to-equity ratio of 148.29, a current ratio of 2.62 and a quick ratio of 6.97.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Read More
- Five stocks we like better than Celadon Pharmaceuticals
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 High-Yield Dividend Stocks Analysts Favor as Rates Drop
- How to Use the MarketBeat Stock Screener
- 3 Momentum Trades Too Good Pass Up
- What Are Dividends? Buy the Best Dividend Stocks
- Opportunity Knocks: Buy the Dip on Permian Resources Stock?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
